These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8594306)

  • 21. Activation of soluble guanylate cyclase by nitrovasodilators is inhibited by oxidized low-density lipoprotein.
    Schmidt K; Graier WF; Kostner GM; Mayer B; Kukovetz WR
    Biochem Biophys Res Commun; 1990 Oct; 172(2):614-9. PubMed ID: 1978674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relation between human platelet aggregation and activation of soluble platelet guanylate cyclase].
    Chirkov IuIu; Tyshchuk IA; Severina IS
    Vopr Med Khim; 1990; 36(4):57-60. PubMed ID: 1978441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Soluble guanylate cyclase from rat platelets during experimental myocardial ischemia].
    Busygina OG; Koloskov IuB; Demurov EA; Severina IS
    Vopr Med Khim; 1990; 36(5):24-6. PubMed ID: 1979194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors affecting the activity of guanylate cyclase in lysates of human blood platelets.
    Adams AF; Haslam RJ
    Biochem J; 1978 Jul; 174(1):23-35. PubMed ID: 29607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Heme deficiency of soluble guanylate cyclase in rat platelets].
    Busygina OG; Severina IS
    Biokhimiia; 1991 Mar; 56(3):487-93. PubMed ID: 1679351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of guanylate cyclase and phosphodiesterases in the functional heterogeneity of human blood platelet subpopulations.
    Opper C; Schrumpf E; Gear AR; Wesemann W
    Thromb Res; 1995 Dec; 80(6):461-70. PubMed ID: 8610274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of nitroso complexes of some transition metals on the activity of soluble guanylate cyclase.
    Severina IS; Bussygina OG; Grigorjev NB
    Biochem Int; 1992 Mar; 26(4):695-705. PubMed ID: 1351725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of carnosine in the function of soluble of guanylate cyclase].
    Severina IS; Busygina OG
    Biokhimiia; 1992 Sep; 57(9):1330-6. PubMed ID: 1361362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Potentiation of NO-dependent activation of soluble guanylate cyclase by polyamines].
    Severina IS; Piatakova NV; Shchegolev AIu
    Biomed Khim; 2007; 53(1):44-9. PubMed ID: 17436683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Changes in the guanylate cyclase activity of human thrombocytes during ADP-inducible aggregation].
    Chirkov IuIu; Belushkina NN; Tyshchuk IA; Severina IS
    Biull Eksp Biol Med; 1991 Feb; 111(2):152-4. PubMed ID: 1677293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.
    Radomski MW; Palmer RM; Moncada S
    Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5193-7. PubMed ID: 1695013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of heme in the regulation of human and rat platelet soluble guanylate cyclases.
    Severina IS; Busygina OG
    Biochem Int; 1991 Apr; 23(6):1143-54. PubMed ID: 1683234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Soluble platelet guanylate cyclase: significance of heme in regulating enzymatic activity and the role of the enzyme in platelet aggregation].
    Severina IS
    Biokhimiia; 1994 Mar; 59(3):325-39. PubMed ID: 7910045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of 8-substituted cyclic AMP derivatives on soluble guanylate cyclase activity from human platelets.
    Sasaki Y; Ikukawa S; Hidaka H
    Jpn J Pharmacol; 1981 Jun; 31(3):355-9. PubMed ID: 6118448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium-induced release from platelet membranes of fatty acids that modulate soluble guanylate cyclase.
    Gerzer R; Hamet P; Ross AH; Lawson JA; Hardman JG
    J Pharmacol Exp Ther; 1983 Jul; 226(1):180-6. PubMed ID: 6134818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation.
    Severina IS; Belushkina NN; Grigoryev NB
    Biochem Mol Biol Int; 1994 Aug; 33(5):957-67. PubMed ID: 7987264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basal activities of adenylate and guanylate cyclase in lymphocytes and platelets of alcoholics.
    Anokina IP; Kogan BM; Nickel B; Schulz R; Kemper A
    Biomed Biochim Acta; 1989; 48(8):593-6. PubMed ID: 2575902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrial natriuretic factor and sodium nitroprusside increase cyclic GMP in cultured rat lung fibroblasts by activating different forms of guanylate cyclase.
    Leitman DC; Agnost VL; Tuan JJ; Andresen JW; Murad F
    Biochem J; 1987 May; 244(1):69-74. PubMed ID: 2889449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carnosine as a regulator of soluble guanylate cyclase.
    Severina IS; Bussygina OG; Pyatakova NV
    Biochemistry (Mosc); 2000 Jul; 65(7):783-8. PubMed ID: 10951096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of soluble guanylate cyclase by carbon monoxide and inhibition by superoxide anion.
    Brüne B; Schmidt KU; Ullrich V
    Eur J Biochem; 1990 Sep; 192(3):683-8. PubMed ID: 1976516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.